The author of that SA article sounded like an amateur, but that isn’t a surprise with SA.
My best guess would be that the US institutional investors get tapped next. They set up that avenue last year.
I also beleive this because SI has indicated that he doesn’t want to partner the paediatric aGVHD program- which is what the phase 3 trial was for.
Instead he wants to partner the adult aGVHD, class 2/3 CHF (not class 4), RA and chronic lower back pain programs.
There does appear to be a strong shift in sentiment after the phase 3 success though, so you could be right- that may be the catalyst to CHF or chronic lower back pain getting over the line.
So I would be very happy to be proven wrong
- Forums
- ASX - By Stock
- MSB
- Cell Therapy News/Articles
Cell Therapy News/Articles, page-158
-
- There are more pages in this discussion • 17,648 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.05 |
Change
0.080(8.25%) |
Mkt cap ! $1.198B |
Open | High | Low | Value | Volume |
99.5¢ | $1.06 | 99.0¢ | $4.930M | 4.779M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 23545 | $1.05 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.05 | 339479 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 23545 | 1.045 |
1 | 10000 | 1.040 |
8 | 181213 | 1.035 |
15 | 391706 | 1.030 |
1 | 15570 | 1.025 |
Price($) | Vol. | No. |
---|---|---|
1.050 | 339479 | 5 |
1.055 | 21365 | 3 |
1.060 | 376981 | 13 |
1.065 | 55888 | 5 |
1.070 | 93334 | 6 |
Last trade - 16.10pm 04/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |